Cargando…
Supervised Machine‐Learning Reveals That Old and Obese People Achieve Low Dapsone Concentrations
The human species is becoming increasingly obese. Dapsone, which is extensively used across the globe for dermatological disorders, arachnid bites, and for treatment of several bacterial, fungal, and parasitic diseases, could be affected by obesity. We performed a clinical experiment, using optimal...
Autores principales: | Hall, RG, Pasipanodya, JG, Swancutt, MA, Meek, C, Leff, R, Gumbo, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572360/ https://www.ncbi.nlm.nih.gov/pubmed/28575552 http://dx.doi.org/10.1002/psp4.12208 |
Ejemplares similares
-
Fractal Geometry‐Based Decrease in Trimethoprim‐Sulfamethoxazole Concentrations in Overweight and Obese People
por: Hall, RG, et al.
Publicado: (2016) -
Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar
por: Song, Jaewoo
Publicado: (2017) -
Methemoglobinemia in a 28-year-old woman treated with dapsone
por: Jacob, Gabriella, et al.
Publicado: (2022) -
Dapsone in dermatology and beyond
por: Wozel, Gottfried, et al.
Publicado: (2013) -
Dapsone-Induced Hypoxia
por: Keerty, Dinesh, et al.
Publicado: (2020)